Bayer, the German petrochemical giant, has taken steps to merge its American subsidiary, KWA Investment, with American agro-chemical and seed producer Monsanto. The deal would involve the dissolution of KWA as a legal entity, meaning Monsanto would remain after the merger.
Bayer has sought approval for this move from Colombian regulators, who will now determine whether the union of Monsanto’s and Bayer’s Colombian operations are likely to restrict competition.
Full Content: El Tiempo
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Competition Office to Scrutinize High Electricity Prices in Germany
Jan 2, 2025 by
CPI
Mexican Lawmakers Advance Controversial Plan to Dissolve Independent Oversight Bodies
Jan 2, 2025 by
CPI
Motorola Accuses UK of Antitrust Breach Over Terminated Emergency Services Contract
Jan 2, 2025 by
CPI
Amazon Must Face Antitrust Case Over Alleged Monopoly Practices
Jan 2, 2025 by
CPI
US Appeals Court Blocks FCC’s Move to Reinstate Net Neutrality Rules
Jan 2, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand